Cannon Global Investment Management, LLC Ironwood Pharmaceuticals Inc Transaction History

Cannon Global Investment Management, LLC

  • $57.1 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 04, 2022
SELL
$10.86 - $13.95 $477,840 - $613,800
-44,000 Closed
0 $0
Q3 2021

Oct 27, 2021
BUY
$11.92 - $13.92 $524,480 - $612,480
44,000 New
44,000 $575,000
Q2 2021

Aug 03, 2021
SELL
$10.16 - $13.11 $325,120 - $419,520
-32,000 Closed
0 $0
Q1 2021

May 06, 2021
BUY
$9.04 - $11.86 $289,280 - $379,520
32,000 New
32,000 $358,000

Others Institutions Holding IRWD

# of Institutions
238
Shares Held
162M
Call Options Held
11.2M
Put Options Held
9.1K
View Full List

About IRONWOOD PHARMACEUTICALS INC

IRWD Quotes by TradingView
  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $539M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track Cannon Global Investment Management, LLC Portfolio

Follow Cannon Global Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cannon Global Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cannon Global Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email